Super V3 Investment Limited Partnership Jafco, 10% Owner at Tracon Pharmaceuticals, Inc. (TCON), bought 257,950 shares at $10.00 ($2.6M) on 2015-02-04, disclosed to the SEC on 2015-02-17.
Open-market purchase of $2.6M TCON by 10% Owner. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Negative factors outweigh the positive ones.
| Filing → |
| TCON | SELL | 2015-10-13 | $32K | — | Filing → |
| TCON | SELL | 2015-10-08 | $221K | — | Filing → |
| TCON | SELL | 2015-10-06 | $152K | — | Filing → |